Liquid Biopsy: How Circulating Tumor DNA Is Changing Cancer Monitoring

Liquid biopsy using circulating tumor DNA (ctDNA) is transforming cancer care by enabling non-invasive, real-time monitoring of tumors through simple blood tests. It detects recurrence earlier, guides treatment changes, and reduces the need for painful tissue biopsies.

Read More